Coccidioidomycosis, unspecified
ICD-10 B38.4 is a billable code used to indicate a diagnosis of coccidioidomycosis, unspecified.
Coccidioidomycosis, commonly known as Valley Fever, is a fungal infection caused by the inhalation of spores from the Coccidioides species, primarily C. immitis and C. posadasii. This infection is endemic to certain regions, particularly the southwestern United States, parts of Mexico, and Central and South America. The disease can manifest in various forms, ranging from asymptomatic to severe pulmonary infections, and can disseminate to other parts of the body, including the skin, bones, and central nervous system. Patients may present with flu-like symptoms such as fever, cough, chest pain, and fatigue. In immunocompromised individuals, such as those with HIV/AIDS, cancer, or those on immunosuppressive therapies, the risk of severe disease and dissemination is significantly increased. Diagnosis is typically made through clinical evaluation, serological tests, and imaging studies. Treatment often involves antifungal medications, with fluconazole and itraconazole being the most commonly prescribed. In severe cases, amphotericin B may be indicated. The unspecified designation of this code indicates that the specific manifestation or severity of the disease has not been documented, which can complicate treatment and management.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with respiratory symptoms, fever, and travel history to endemic areas.
Documentation must clearly indicate the immunocompromised status of the patient if applicable.
Pulmonary function tests, imaging results, and treatment response documentation.
Patients with chronic cough and chest pain who have a history of exposure to Coccidioides.
Ensure that any pulmonary complications are well documented to support coding.
Used to confirm diagnosis in suspected cases of coccidioidomycosis.
Document the reason for testing and the clinical findings leading to the test.
Infectious disease specialists should ensure comprehensive documentation of the patient's history and exposure.
Common symptoms include fever, cough, chest pain, fatigue, and in some cases, skin rashes or joint pain. Severe cases may lead to pneumonia or disseminated disease.
Diagnosis is typically made through clinical evaluation, serological tests for antibodies, and imaging studies to assess pulmonary involvement.
Common antifungal treatments include fluconazole and itraconazole for mild to moderate cases, while amphotericin B may be used for severe cases.
